Head and Neck Cancer Diagnostics Market Size | Forecast 2030

Segments - Head and Neck Cancer Diagnostics Market by Diagnostic Methods (Endoscopy Screening Equipment, Diagnostic Imaging Equipment, Bioscopy Screening Tests, Dental Diagnostic Methods, and Others), End-users (Diagnostic Centers, and Hospitals), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The global head and neck cancer diagnostics market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to rising prevalence of cancer across the globe.

Head and Neck Cancer Diagnostics Market Key Takeaways

Head and neck cancer are particularly found in people with high alcohol consumption and smoking habit. These types of cancer have high chances of being cured if detected early and treated promptly. The increased frequency of diagnostic procedures for head and neck cancer, especially pharyngeal and oral malignancies, is one of the reasons driving the market expansion. Head & neck cancers include a number of different malignant tumors that develop in or around the throat, sinuses, lips, salivary glands, larynx, nose, and mouth. Head and neck cancer are treated with a variety of medications, which can be used alone or in conjunction.
The COVID-19 pandemic has been declared a public-health emergency by the World Health Organization (WHO). The treatment and diagnosis of patients with head and neck cancer have been severely impacted by the COVID 19 epidemic. The market, on the other hand, is expected to return to normalcy soon and to grow at substantial rate during the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

Increasing demand for advancements in treatment modes, diagnostic imaging, and incorporating new technologies in diagnostic equipment is estimated to drive the market growth during the forecast period
Rising intake of tobacco and alcohol products is fueling the demand for the head and neck cancer diagnostics market.
Increasing support from private and public organizations through investments is estimated to create growth opportunities for the head and neck cancer diagnostics market.

Scope of the Report

The report on the global head and neck cancer diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Head and Neck Cancer Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Diagnostic Methods (Endoscopy Screening Equipment, Diagnostic Imaging Equipment, Bioscopy Screening Tests, Dental Diagnostic Methods, Others), and End-users (Diagnostic Centers, and Hospitals)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Philips; Siemens Healthineers; GE Healthcare; Apteryx Imaging Inc; and Identafi

Head and Neck Cancer Diagnostics Market Segment Insights

Diagnostic imaging equipment segment is expected to grow at a rapid pace

Based on diagnostic methods, the market is divided into endoscopy screening equipment, diagnostic imaging equipment, bioscopy screening tests, dental diagnostic methods, others. The diagnostic imaging equipment segment is expected to grow at a rapid pace during the forecast period owing to expanding availability of different types of treatment procedures. increasing spending on diagnostic imaging equipment is expected to boost the segment growth.

Diagnostic centers segment is projected to expand at a considerable CAGR

On the basis of end-users, the market is segregated into diagnostic centers and hospitals. The diagnostic centers segment is projected to expand at a considerable CAGR during the forecast period due to growing concerns towards the patient's health condition and government plans to decrease the cost of treatment.

North America is anticipated to constitute a key market share

In terms of regions, the global head and neck cancer diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to increasing capital income in both developing and developed countries and the quick acceptance of advanced technologies. However, the market in Latin America is anticipated to expand at a rapid pace during the forecast period due to growing demand for appropriate treatment procedures the diseases.

Head and Neck Cancer Diagnostics Market By Regions

Segments

The global head and neck cancer diagnostics market has been segmented on the basis of

Diagnostic Methods

Endoscopy Screening Equipment
Diagnostic Imaging Equipment
Bioscopy Screening Tests
Dental Diagnostic Methods
Others

End-users

Diagnostic Centers
Hospitals

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Philips
Siemens Healthineers
GE Healthcare
Apteryx Imaging Inc
Identafi

Competitive Landscape

Key players competing in the global head and neck cancer diagnostics market are Philips; Siemens Healthineers; GE Healthcare; Apteryx Imaging Inc; and Identafi.

Industry leaders have built their position in the market by investing more in research and having a superior distribution system.

Head and Neck Cancer Diagnostics Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Head and Neck Cancer Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Head and Neck Cancer Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Head and Neck Cancer Diagnostics Market - Supply Chain
  4.5. Global Head and Neck Cancer Diagnostics Market Forecast
     4.5.1. Head and Neck Cancer Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Head and Neck Cancer Diagnostics Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Head and Neck Cancer Diagnostics Market Absolute $ Opportunity
5. Global Head and Neck Cancer Diagnostics Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Head and Neck Cancer Diagnostics Market Size and Volume Forecast by End Users
     5.3.1. Diagnostic Centers Hospitals
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Head and Neck Cancer Diagnostics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Head and Neck Cancer Diagnostics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Head and Neck Cancer Diagnostics Demand Share Forecast, 2019-2026
7. North America Head and Neck Cancer Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Head and Neck Cancer Diagnostics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Head and Neck Cancer Diagnostics Market Size and Volume Forecast by End Users
     7.4.1. Diagnostic Centers Hospitals
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Head and Neck Cancer Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Head and Neck Cancer Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Head and Neck Cancer Diagnostics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Head and Neck Cancer Diagnostics Market Size and Volume Forecast by End Users
     8.4.1. Diagnostic Centers Hospitals
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Head and Neck Cancer Diagnostics Demand Share Forecast, 2019-2026
9. Europe Head and Neck Cancer Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Head and Neck Cancer Diagnostics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Head and Neck Cancer Diagnostics Market Size and Volume Forecast by End Users
     9.4.1. Diagnostic Centers Hospitals
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Head and Neck Cancer Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Head and Neck Cancer Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Head and Neck Cancer Diagnostics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Head and Neck Cancer Diagnostics Market Size and Volume Forecast by End Users
     10.4.1. Diagnostic Centers Hospitals
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Head and Neck Cancer Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Head and Neck Cancer Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Head and Neck Cancer Diagnostics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Head and Neck Cancer Diagnostics Market Size and Volume Forecast by End Users
     11.4.1. Diagnostic Centers Hospitals
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Head and Neck Cancer Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Head and Neck Cancer Diagnostics Market: Market Share Analysis
  12.2. Head and Neck Cancer Diagnostics Distributors and Customers
  12.3. Head and Neck Cancer Diagnostics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Philips Siemens Healthineers GE Healthcare Apteryx Imaging Inc Identafi